Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 19, 2019 - Issue 6
Submit an article Journal homepage
1,832
Views
40
CrossRef citations to date
0
Altmetric
Review

Prodrugs for targeted cancer therapy

Carla SouzaCenter of Nanotechnology and Tissue Engineering, Department of Chemistry, School of Philosophy, Sciences and Letters of Ribeirão Preto- USP, Ribeirão Preto, BrazilView further author information
,
Diogo Silva PellosiDepartment of Chemistry, Laboratory of Hybrid Materials, Federal University of São Paulo - UNIFESP, Diadema, BrazilView further author information
&
Antonio Claudio TedescoCenter of Nanotechnology and Tissue Engineering, Department of Chemistry, School of Philosophy, Sciences and Letters of Ribeirão Preto- USP, Ribeirão Preto, BrazilCorrespondence[email protected]
View further author information
Pages 483-502 | Received 14 Feb 2019, Accepted 03 May 2019, Published online: 13 May 2019

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lanshu Xiao, Yi Liu, Hui Chen & Lisong Shen. (2023) Targeting CDK9 with selective inhibitors or degraders in tumor therapy: an overview of recent developments. Cancer Biology & Therapy 24:1.
Read now
Zhen Qu, Yuning Ren, Hongyu Shen, Huihui Wang, Lijie Shi & Deyong Tong. (2021) Combination Therapy of Metastatic Castration-Recurrent Prostate Cancer: Hyaluronic Acid Decorated, Cabazitaxel-Prodrug and Orlistat Co-Loaded Nano-System. Drug Design, Development and Therapy 15, pages 3605-3616.
Read now

Articles from other publishers (38)

Viktorija Preitakaitė, Povilas Barasa, Agota Aučynaitė, Gediminas Plakys, Martyna Koplūnaitė, Simona Zubavičiūtė & Rolandas Meškys. (2023) Bacterial amidohydrolases and modified 5-fluorocytidine compounds: Novel enzyme-prodrug pairs. PLOS ONE 18:11, pages e0294696.
Crossref
Fatemeh Moradbeygi, Younes Ghasemi, Ahmad Reza Farmani & Shiva Hemmati. (2023) Glucarpidase (carboxypeptidase G2): Biotechnological production, clinical application as a methotrexate antidote, and placement in targeted cancer therapy. Biomedicine & Pharmacotherapy 166, pages 115292.
Crossref
Sofia A. G. Monteiro, Pedro M. P. Gois & João P. M. António. (2023) Boronic Acids and Beyond: ROS-Responsive Prodrugs as Tools for a Safer and More Effective Cancer Chemotherapy. Synlett.
Crossref
J. Peter Lee, Broderick C. Corless, Thomas J. Gardner, David A. Scheinberg & Derek S. Tan. (2023) Development of a p -Hydroxybenzyl-Alcohol-Linked Glutamate Prodrug for Activation by Pseudomonas Carboxypeptidase G2 . Organic Letters 25:34, pages 6295-6299.
Crossref
Siyue Ma, Ji Hyeon Kim, Wei Chen, Lu Li, Jieun Lee, Junlian Xue, Yuxia Liu, Guang Chen, Bo Tang, Wei Tao & Jong Seung Kim. (2023) Cancer Cell‐Specific Fluorescent Prodrug Delivery Platforms. Advanced Science 10:16.
Crossref
Tinghe Yu & Xinya Li. (2023) Development of ZD2767P–carboxypeptidase G2–ultrasound therapy against cisplatin-resistant cancer. Frontiers in Oncology 13.
Crossref
Xiaofeng Xie, Siyuan Kong & Weiqian Cao. (2023) Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases. Frontiers in Immunology 14.
Crossref
Ragini D. SinghAvadhesh AvadheshGaurav SharmaSagar DholariyaRima B. ShahBela GoyalSubash Chandra Gupta. (2023) Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy. Antioxidants & Redox Signaling 38:10-12, pages 853-876.
Crossref
Gabriela Pastuch-Gawołek, Julia Szreder, Monika Domińska, Mateusz Pielok, Piotr Cichy & Mirosława Grymel. (2023) A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy. Pharmaceutics 15:3, pages 913.
Crossref
Weiyan Cheng, Shasha Li, Siyuan Han, Ruoyang Miao, Suhua Wang, Chunxia Liu, Han Wei, Xin Tian & Xiaojian Zhang. (2023) Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands. Bioorganic & Medicinal Chemistry 82, pages 117237.
Crossref
Tayo Alex Adekiya & Oluwanifemi Owoseni. (2023) Emerging frontiers in nanomedicine targeted therapy for prostate cancer. Cancer Treatment and Research Communications 37, pages 100778.
Crossref
Catriona C. James, Dinghao Wu, Eduard O. Bobylev, Alexander Kros, Bas de Bruin & Joost N. H. Reek. (2022) Protection of a Gold Catalyst by a Supramolecular Cage Improves Bioorthogonality. ChemCatChem 14:23.
Crossref
Liangkui Hu, Bing Li, Yulong Liao, Simeng Wang, Peng Hou, Yangyang Cheng & Shiyong Zhang. (2022) Nitroreductase-induced bioorthogonal ligation for prodrug activation: A traceless strategy for cancer-specific imaging and therapy. Bioorganic Chemistry 129, pages 106167.
Crossref
Rana Rais, Kathryn M. Lemberg, Lukáš Tenora, Matthew L. Arwood, Arindom Pal, Jesse Alt, Ying Wu, Jenny Lam, Joanna Marie H. Aguilar, Liang Zhao, Diane E. Peters, Carolyn Tallon, Rajeev Pandey, Ajit G. Thomas, Ranjeet P. DashTanguy Seiwert, Pavel Majer, Robert D. Leone, Jonathan D. Powell & Barbara S. Slusher. (2022) Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug. Science Advances 8:46.
Crossref
Larasati Larasati, Witri Wahyu Lestari & Maulidan Firdaus. (2022) Dual-Action Pt(IV) Prodrugs and Targeted Delivery in Metal-Organic Frameworks: Overcoming Cisplatin Resistance and Improving Anticancer Activity. Bulletin of the Chemical Society of Japan 95:11, pages 1561-1577.
Crossref
Qianfen Liu, Xinya Li, Yuanyuan Luo, Houmei Wang, Ying Zhang & Tinghe Yu. (2022) Ultrasonically Enhanced ZD2767P–Carboxypeptidase G2 Deactivates Cisplatin-Resistant Human Lung Cancer Cells. Oxidative Medicine and Cellular Longevity 2022, pages 1-14.
Crossref
Linlin Sun, Pan Zhao, Menghan Chen, Jiayi Leng, Yixin Luan, Baoxiang Du, Jia Yang, Yong Yang & Rong Rong. (2022) Taxanes prodrug-based nanomedicines for cancer therapy. Journal of Controlled Release 348, pages 672-691.
Crossref
Xinzhu Shan, Zhiqiang Zhao, Chen Wang, Jin Sun, Zhonggui He, Cong Luo & Shenwu Zhang. (2022) Emerging Prodrug-Engineered nanomedicines for synergistic Chemo-Phototherapy. Chemical Engineering Journal 442, pages 136383.
Crossref
Xiaolu Chen, Rongying Ma, Zhaoming Fu, Qianhong Su, Xingyu Luo, Yingchao Han, Yong Yang & Qingchun Deng. (2022) Metal-phenolic networks-encapsulated cascade amplification delivery nanoparticles overcoming cancer drug resistance via combined starvation/chemodynamic/chemo therapy. Chemical Engineering Journal 442, pages 136221.
Crossref
Xiaofeng Dai, Linhan Cai & Fule He. (2022) Single-cell sequencing: expansion, integration and translation. Briefings in Functional Genomics 21:4, pages 280-295.
Crossref
Philip Serwer. (2022) A Perspective on Studies of Phage DNA Packaging Dynamics. International Journal of Molecular Sciences 23:14, pages 7854.
Crossref
Xiao Dong, Rajeev K. Brahma, Chao Fang & Shao Q. Yao. (2022) Stimulus-responsive self-assembled prodrugs in cancer therapy. Chemical Science 13:15, pages 4239-4269.
Crossref
Qing Huang, Chun Hua Yan, Sheng Xia Luo, Zhi Xin Li, Tai Bao Wei & Zhi Zhong Wang. (2022) Synthesis, Characteristics, and Pharmaceutical Properties of Ibuprofen-Cyclodextrin-PEG Conjugate. Journal of Chemistry 2022, pages 1-7.
Crossref
João Franco Machado & Tânia S. Morais. (2022) Are smart delivery systems the solution to overcome the lack of selectivity of current metallodrugs in cancer therapy?. Dalton Transactions 51:7, pages 2593-2609.
Crossref
Chahrazed Bouzriba, Atziri Corin Chavez Alvarez, Mathieu Gagné-Boulet, Vincent Ouellette, Jacques Lacroix, Marie-France Côté, René C.-Gaudreault & Sébastien Fortin. (2022) Branched alkyl of phenyl 4-(2-oxo-3-alkylimidazolidin-1-yl)benzenesulfonates as unique cytochrome P450 1A1-activated antimitotic prodrugs: Biological evaluation and mechanism of bioactivation. European Journal of Medicinal Chemistry 229, pages 114003.
Crossref
Feray Kockar, Esra Tokay & Nelin Hacioglu. 2022. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases. Combination Drug Delivery Approach as an Effective Therapy for Various Diseases 239 271 .
Giredhar Muthiah & Amit Jaiswal. (2021) Can the Union of Prodrug Therapy and Nanomedicine Lead to Better Cancer Management?. Advanced NanoBiomed Research 2:1.
Crossref
Jie Wang, Yukun Zhang, Jiuchan Pi, Dongming Xing & Chao Wang. (2021) Localized delivery of immunotherapeutics: A rising trend in the field. Journal of Controlled Release 340, pages 149-167.
Crossref
Weiyan Cheng, Shasha Li, Xueqian Wen, Siyuan Han, Suhua Wang, Han Wei, Zhizhen Song, Yueqin Wang, Xin Tian & Xiaojian Zhang. (2021) Development of hypoxia-activated PROTAC exerting a more potent effect in tumor hypoxia than in normoxia. Chemical Communications 57:95, pages 12852-12855.
Crossref
Yajing Sun, Qingshan Yang, Xue Xia, Xiaozhe Li, Weimin Ruan, Meng Zheng, Yan Zou & Bingyang Shi. (2021) Polymeric Nanoparticles for Mitochondria Targeting Mediated Robust Cancer Therapy. Frontiers in Bioengineering and Biotechnology 9.
Crossref
Irina Alekseenko, Alexey Kuzmich, Liya Kondratyeva, Sofia Kondratieva, Victor Pleshkan & Eugene Sverdlov. (2021) Step-by-Step Immune Activation for Suicide Gene Therapy Reinforcement. International Journal of Molecular Sciences 22:17, pages 9376.
Crossref
Henrik Franzyk & Søren Brøgger Christensen. (2021) Targeting Toxins toward Tumors. Molecules 26:5, pages 1292.
Crossref
Sena Karaosmanoglu, Mengjiao Zhou, Bingyang Shi, Xiujuan Zhang, Gareth R. Williams & Xianfeng Chen. (2021) Carrier-free nanodrugs for safe and effective cancer treatment. Journal of Controlled Release 329, pages 805-832.
Crossref
Shumeng Li, Xinzhu Shan, Yuequan Wang, Qin Chen, Jin Sun, Zhonggui He, Bingjun Sun & Cong Luo. (2020) Dimeric prodrug-based nanomedicines for cancer therapy. Journal of Controlled Release 326, pages 510-522.
Crossref
Qianfen Liu, Xiaocui Zhong, Ying Zhang, Xinya Li, Guanhua Qian & Tinghe Yu. (2020) Ultrasound Enhances ZD2767P–Carboxypeptidase G2 against Chemoresistant Ovarian Cancer Cells by Altering the Intracellular Pharmacokinetics of ZD2767D. Molecular Pharmaceutics 17:6, pages 1922-1932.
Crossref
Behzadipour & Hemmati. (2019) Considerations on the Rational Design of Covalently Conjugated Cell-Penetrating Peptides (CPPs) for Intracellular Delivery of Proteins: A Guide to CPP Selection Using Glucarpidase as the Model Cargo Molecule. Molecules 24:23, pages 4318.
Crossref
Liangkui Hu, Bing Li, Yulong Liao, Simeng Wang, Peng Hou, Yangyang Cheng & Shiyong Zhang. (2022) Nitroreductase-Induced Bioorthogonal Ligation for Prodrug Activation: A Traceless Strategy for Cancer-Specific Imaging and Therapy. SSRN Electronic Journal.
Crossref
Xiaolu Chen, Rongying Ma, Zhaoming Fu, Qianhong Su, Xingyu Luo, Yingchao Han, Yong Yang & Qingchun Deng. (2021) Metal-Phenolic Networks-Encapsulated Cascade Amplification Delivery Nanoparticles Overcoming Cancer Drug Resistance Via Combined Starvation/Chemodynamic/Chemo Therapy. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.